drugset / Trial / NCT00656552

Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation

NCT00656552

Phase 0 Unknown 100 enrolled Cairo University
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Escitalopram has been claimed to have the highest selectivity for the human serotonin transporter relative to the noradrenaline or dopamine transporters. This might be associated with greater clinical efficacy. Most adverse events reported by escitalopram-treated patients are mild and transient. In this study, we compare escitalopram with placebo in the treatment of PE.

Timeline

Start
2008-05
Primary completion
2008-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg Oral

Indications